UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 20 filers reported holding UROVANT SCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $868,000 | +58.4% | 53,828 | -8.3% | 0.00% | – |
| Q3 2020 | $548,000 | -5.7% | 58,699 | -0.6% | 0.00% | – |
| Q2 2020 | $581,000 | +315.0% | 59,070 | +289.9% | 0.00% | – |
| Q1 2020 | $140,000 | -38.6% | 15,150 | +3.1% | 0.00% | – |
| Q4 2019 | $228,000 | +74.0% | 14,700 | +6.3% | 0.00% | – |
| Q3 2019 | $131,000 | -3.7% | 13,833 | -19.4% | 0.00% | – |
| Q2 2019 | $136,000 | +22.5% | 17,164 | +55.8% | 0.00% | – |
| Q1 2019 | $111,000 | – | 11,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 157,480 | $1,246,000 | 0.82% |
| Prosight Management, LP | 142,620 | $1,128,000 | 0.57% |
| Sio Capital Management, LLC | 220,042 | $1,741,000 | 0.42% |
| Perceptive Advisors | 1,875,426 | $14,835,000 | 0.34% |
| Park West Asset Management LLC | 432,500 | $3,421,000 | 0.14% |
| Eventide Asset Management | 401,558 | $3,176,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $7,910,000 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 51,100 | $404,000 | 0.01% |
| Weiss Multi-Strategy Advisers LLC | 25,000 | $198,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 438,911 | $3,472,000 | 0.01% |